ViaMune, Inc., based in Athens, Georgia, is a privately-held preclinical stage company with a mission to enable immunotherapy for patients with advanced cancers. ViaMune offers a fully synthetic vaccine platform that generates robust immune responses to tumor-specific targets. ViaMune's patented technology provides a unique path to targeting structures found only on tumor cells. ViaMune is anchored by a leadership team with deep experience in oncology and pharmaceutical development.
| Website | http://www.viamune.com |
| Revenue | $4 million |
| Employees | View employees |
| Founded | 2011 |
| Address | 220 Riverbend Rd, Athens, Georgia 30602, US |
| Phone | +1 706-372-4261 |
| Industry | Manufacturing General, Biotechnology, Manufacturing, Science and Engineering |
| Competitors | Humana, CVS Health, Walgreens Boots Alliance, Anthem Health Plans, Inc., Cigna Healthcare, WellCare Health Plans, Aetna, a CVS Health Company, UnitedHealth Group, Centene Corporation, KAISER PERMANENTE DIVISION OF RESEARCH +40 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 80 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular ViaMune employee's phone or email?
ViaMune Questions
The ViaMune annual revenue was $4 million in 2026.
ViaMune is based in Athens, Georgia.
The NAICS codes for ViaMune are [325, 32, 3254].
The SIC codes for ViaMune are [283, 80, 28].
